4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-5-amine

Catalog No. :
ACFJPD325
CAS No. :
866216-20-8
Molecular Formula :
C7H11N3
Molecular Weight :
137.19

IUPAC Name:4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-5-amine

4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-5-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$340.00Login to see priceIn stockInquiry
250mg97%$569.00Login to see priceIn stockInquiry
500mg97%$946.00Login to see priceIn stockInquiry
1g97%$1420.00Login to see priceIn stockInquiry
5g97%$4258.00Login to see priceIn stockInquiry
10g97%$7097.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-5-amine
IUPAC Name4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-5-amine
MDL No.MFCD13176247
Molecular FormulaC7H11N3
Molecular Weight137.19
SMILESNC1CCN2N=CC=C2C1
InChI KeyJJNXSQRHVCZLAK-UHFFFAOYSA-N
SynonymDTXSID30717432 | 5-amino-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine | EN300-105462 | MFCD13176247 | SCHEMBL24035779 | 4,5,6,7-Tetrahydropyrazolo[1,5-a]pyridin-5-amine | 4H,5H,6H,7H-pyrazolo[1,5-a]pyridin-5-amine | AKOS006349855 | PS-15756 | P18182 | SY0337
CAS No.866216-20-8
PubChem CID55284769

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFJPD325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFJPD325 route product structure diagram
    ACFJPD325866216-20-8 In Stock
Inquiry

2. ACFJPD325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFJPD325 route product structure diagram
    ACFJPD325866216-20-8 In Stock
Inquiry

Comments (0)